Financials, Technology, Healthcare Nov 29, 2021 04:19 PM (GMT+8) · EqualOcean
Financial Associated Press, November 29 - Zhenghai biology announced that the company's product "active biological bone" has recently completed the submission of "Supplementary information" of the product in accordance with the relevant requirements of the "information supplementary notice" of the medical device technical evaluation center of the State Drug Administration ("State Drug Administration") for the technical evaluation stage of the product, and entered the state of "main review".
Related companies: